VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 53 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $189,000 | +10.5% | 15,125 | 0.0% | 0.02% | +14.3% |
| Q2 2021 | $171,000 | -25.3% | 15,125 | 0.0% | 0.02% | -34.4% |
| Q1 2021 | $229,000 | +31.6% | 15,125 | 0.0% | 0.03% | +23.1% |
| Q4 2020 | $174,000 | +1.2% | 15,125 | -3.2% | 0.03% | -25.7% |
| Q2 2020 | $172,000 | +0.6% | 15,625 | 0.0% | 0.04% | -16.7% |
| Q1 2020 | $171,000 | -23.7% | 15,625 | +10.6% | 0.04% | -30.0% |
| Q4 2019 | $224,000 | +22.4% | 14,125 | +13.9% | 0.06% | +17.6% |
| Q3 2019 | $183,000 | +46.4% | 12,400 | 0.0% | 0.05% | +34.2% |
| Q2 2019 | $125,000 | -6.7% | 12,400 | 0.0% | 0.04% | -24.0% |
| Q1 2019 | $134,000 | +32.7% | 12,400 | 0.0% | 0.05% | +16.3% |
| Q4 2018 | $101,000 | -42.0% | 12,400 | +15.9% | 0.04% | -47.6% |
| Q3 2018 | $174,000 | -17.5% | 10,700 | 0.0% | 0.08% | -22.6% |
| Q2 2018 | $211,000 | – | 10,700 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |